Tranzyme Pharma (TZYM) announced that its CFO, Richard Eisenstadt, is resigning effective...

|By:, SA News Editor

Tranzyme Pharma (TZYM) announced that its CFO, Richard Eisenstadt, is resigning effective January 4, 2013, to pursue a new career opportunity. Upon that date, TZYM's controller, Rhonda Stanley, will assume the duties of principal financial officer and principal accounting officer.